Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.

Hu G, Lai P, Liu M, Xu L, Guo Z, Liu H, Li W, Wang G, Yao X, Zheng J, Xu Y.

Tumour Biol. 2014 Nov;35(11):11443-53. doi: 10.1007/s13277-014-2476-x. Epub 2014 Aug 15.

PMID:
25123268
2.

miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.

Kim TH, Song JY, Park H, Jeong JY, Kwon AY, Heo JH, Kang H, Kim G, An HJ.

Cancer Lett. 2015 Jan 28;356(2 Pt B):937-45. doi: 10.1016/j.canlet.2014.11.011. Epub 2014 Nov 10.

PMID:
25444913
3.

MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.

Machackova T, Mlcochova H, Stanik M, Dolezel J, Fedorko M, Pacik D, Poprach A, Svoboda M, Slaby O.

Tumour Biol. 2016 Nov;37(11):14653-14658. Epub 2016 Sep 12.

PMID:
27619681
4.

Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Zhang G, Zhang Z, Liu Z.

Tumour Biol. 2013 Jun;34(3):1887-94. doi: 10.1007/s13277-013-0732-0. Epub 2013 Mar 14.

PMID:
23494182
5.

Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.

Tang Y, Jiang L, Tang W.

Pathol Oncol Res. 2014 Oct;20(4):829-37. doi: 10.1007/s12253-014-9761-2. Epub 2014 May 1.

PMID:
24789683
6.

miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.

Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM.

Oncotarget. 2015 Nov 10;6(35):37808-23. doi: 10.18632/oncotarget.5676.

7.

microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.

Liu C, Yang H, Xu Z, Li D, Zhou M, Xiao K, Shi Z, Zhu L, Yang L, Zhou R.

J Cancer Res Clin Oncol. 2015 Mar;141(3):431-41. doi: 10.1007/s00432-014-1836-7. Epub 2014 Sep 23.

PMID:
25245053
8.

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.

PMID:
24242678
9.

Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.

Jiang XL, Zhang Y, Tan B, Luo CL, Wu XH.

Neoplasma. 2014;61(4):416-23. doi: 10.4149/neo_2014_051.

PMID:
24645843
10.

LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.

Yang F, Zhou X, Du S, Zhao Y, Ren W, Deng Q, Wang F, Yuan J.

PLoS One. 2014 Jun 23;9(6):e100557. doi: 10.1371/journal.pone.0100557. eCollection 2014.

11.

MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.

Wang LL, Wang L, Wang XY, Shang D, Yin SJ, Sun LL, Ji HB.

Tumour Biol. 2016 Nov;37(11):15241-15252. Epub 2016 Sep 30.

PMID:
27696291
12.

NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.

Liang ZL, Kang K, Yoon S, Huang SM, Lim JS, Kim JM, Lim JS, Lee HJ.

Ann Surg Oncol. 2012 Aug;19(8):2763-72. doi: 10.1245/s10434-011-2204-3. Epub 2012 Jan 14.

PMID:
22246425
13.

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK.

Mol Carcinog. 2014 Feb;53 Suppl 1:E36-44. doi: 10.1002/mc.21993. Epub 2013 Sep 5.

PMID:
24009195
14.

PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.

Godlewski J, Krazinski BE, Kowalczyk AE, Kiewisz J, Kiezun J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Maslowski Z, Kmiec Z.

Anticancer Res. 2016 Feb;36(2):617-24.

PMID:
26851016
15.

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.

Chen B, Tang H, Liu X, Liu P, Yang L, Xie X, Ye F, Song C, Xie X, Wei W.

Cancer Lett. 2015 Jan 28;356(2 Pt B):410-7. doi: 10.1016/j.canlet.2014.09.028. Epub 2014 Oct 7.

PMID:
25304371
16.

Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.

Li RZ, Wang LM.

World J Surg Oncol. 2016 May 18;14:150. doi: 10.1186/s12957-016-0900-y.

17.

Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.

White-Al Habeeb NM, Di Meo A, Scorilas A, Rotondo F, Masui O, Seivwright A, Gabril M, Girgis AH, Jewett MA, Yousef GM.

Clin Exp Metastasis. 2015 Aug;32(6):531-41. doi: 10.1007/s10585-015-9725-2. Epub 2015 Jun 3.

PMID:
26037892
18.

Expression and functional role of miR-29b in renal cell carcinoma.

Xu Y, Zhu J, Lei Z, Wan L, Zhu X, Ye F, Tong Y.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14161-70. eCollection 2015.

19.

miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.

Du Y, Chen Y, Wang F, Gu L.

Tumour Biol. 2016 Oct;37(10):13557-13569. Epub 2016 Jul 28.

PMID:
27468717
20.

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.

Zhou W, Li Y, Gou S, Xiong J, Wu H, Wang C, Yan H, Liu T.

Oncotarget. 2015 Nov 10;6(35):37557-69. doi: 10.18632/oncotarget.5317.

Supplemental Content

Support Center